Siasun Robot&Automation Co.Ltd(300024) how good and popular is the operation? Clinicians have the most say.
“Now we are doing (surgery) on Saturday and Sunday, but even so, at least one third of the patients have no chance to undergo Siasun Robot&Automation Co.Ltd(300024) surgery.” Professor Wang linhui, director of Urology Department of Changhai Hospital Affiliated to Naval Military Medical University, told scidev.net daily on the sidelines of the “2021 Oriental International Renal Cancer Summit Forum” held recently.
Professor Wang linhui is one of the doctors who first came into contact with Siasun Robot&Automation Co.Ltd(300024) surgery in China and has rich clinical experience in Siasun Robot&Automation Co.Ltd(300024) surgery. In its view, surgery Siasun Robot&Automation Co.Ltd(300024) is a revolutionary technology because it can provide patients with more accurate and better services than traditional surgery.
new favorite of minimally invasive surgery in urology
“We work overtime seven days a week, even on weekends.” the “operation Siasun Robot&Automation Co.Ltd(300024) ” mentioned by Professor Wang linhui refers to the laparoscopic Siasun Robot&Automation Co.Ltd(300024) operation system “Da Vinci operation Siasun Robot&Automation Co.Ltd(300024) “.
It is developed and produced by American intuitive surgery and is considered to be the most commercially successful surgery Siasun Robot&Automation Co.Ltd(300024) . Its Chinese agent is intuitive Fosun, a joint venture between intuitive surgery and Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) (600196. Sh, 02196. HK) ( Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) holds 40%).
From the approved indications, urology is still the Department with the most application of Da Vinci Siasun Robot&Automation Co.Ltd(300024) . According to Xu Bin, senior clinical application director of intuitive Fosun, revealed at the forum, “at present, the proportion of urological surgery has exceeded 46% (China)”. At present, Da Vinci surgery Siasun Robot&Automation Co.Ltd(300024) is still the only surgery Siasun Robot&Automation Co.Ltd(300024) approved for marketing in urology in China.
In the eyes of Professor Wang linhui, Siasun Robot&Automation Co.Ltd(300024) surgery has the advantages that traditional surgery does not have, which can greatly improve the operation efficiency and bring the operation effect unmatched by traditional surgery. “In urology, the operation space of minimally invasive surgery is narrow, especially for complex operations that need functional reconstruction. We all use Siasun Robot&Automation Co.Ltd(300024) .” He said.
According to the reporter of science and Innovation Board daily, at present, the installed capacity of Da Vinci Siasun Robot&Automation Co.Ltd(300024) in China is about 260, most of which are the third-generation Da Vinci SI system, and the installed capacity is still less than one tenth of that of the United States as a whole.
It is worth mentioning that in April this year, Shanghai became the first city in China to incorporate laparoscopic Siasun Robot&Automation Co.Ltd(300024) surgery into medical insurance. According to Professor Wang linhui, before being included in the medical insurance, a da Vinci Siasun Robot&Automation Co.Ltd(300024) operation costs about 30000 yuan. After being included in the medical insurance, patients can be reimbursed 80%.
In addition, domestic enterprises are trying to catch up. at the end of October this year, the “abdominal endoscopic surgery equipment” (miaoshou-s) produced by Shandong Weigao surgery Siasun Robot&Automation Co.Ltd(300024) Co., Ltd. (hereinafter referred to as “Weigao surgery Siasun Robot&Automation Co.Ltd(300024) ) has been approved for listing, which is the first domestic endoscopic surgery Siasun Robot&Automation Co.Ltd(300024) approved in China. However, Weigao miaohou-s is mainly applicable to cholecystectomy, inguinal hernia surgery, esophageal hiatal hernia repair and gastric fundus folding, fenestration of liver cyst, appendectomy and sleeve gastrectomy, which belong to general surgery.
In other domestic laparoscopic surgery Siasun Robot&Automation Co.Ltd(300024) , according to the prospectus of minimally invasive Siasun Robot&Automation Co.Ltd(300024) -b (02255. HK), tumai, the company’s endoscopic surgery Siasun Robot&Automation Co.Ltd(300024) , has submitted an application for listing and registration of Urology in May this year. Under normal circumstances, tumai is expected to be approved for listing next year.
single hole Siasun Robot&Automation Co.Ltd(300024) surgery is promising
Whether a single hole operation can be performed is an important index to measure whether a endoscopic operation Siasun Robot&Automation Co.Ltd(300024) is excellent or not. Da Vinci SP system is the world’s first and only pure single hole endoscopic surgery Siasun Robot&Automation Co.Ltd(300024) approved for listing. It was approved for two indications in 2018 and 2019, respectively, for urology and specific ear, nose and throat surgery. Gynecological and extrathoracic indications are still in clinical trials.
at present, Da Vinci SP system has not been listed in China. However, according to public information, many domestic endoscopes Siasun Robot&Automation Co.Ltd(300024) in China have intensively carried out single hole laparoscopic surgery , including minimally invasive Siasun Robot&Automation Co.Ltd(300024) -b (02255. HK), Beijing Junrui Technology Co., Ltd. (hereinafter referred to as “Beijing Junrui”), etc.
For example, on December 30, 2020, Professor Zhang Dahong of Zhejiang Provincial People’s hospital operated minimally invasive tumei multi arm endoscope Siasun Robot&Automation Co.Ltd(300024) (non pure single hole Siasun Robot&Automation Co.Ltd(300024) ), and completed China’s first Siasun Robot&Automation Co.Ltd(300024) single hole partial nephrectomy. Recently, minimally invasive tumai single arm endoscopic surgery Siasun Robot&Automation Co.Ltd(300024) has completed China’s first single hole endoscopic Siasun Robot&Automation Co.Ltd(300024) cholecystectomy human trial (first in man, FIM).
compared with imported brands, is there any merit in domestic single hole Siasun Robot&Automation Co.Ltd(300024) surgery?
Professor Wang linhui’s answer is yes. He believes that although single hole laparoscopic surgery Siasun Robot&Automation Co.Ltd(300024) still has some limitations, it can still meet the needs of certain patients. Driven by scientific and technological progress, Siasun Robot&Automation Co.Ltd(300024) assisted single hole laparoscopic surgery will be the development direction in the future.
“Up to now, we have operated domestic surgical sharp surgery Siasun Robot&Automation Co.Ltd(300024) and completed five surgical procedures in urology, including radical prostatectomy. from our practical experience, single hole Siasun Robot&Automation Co.Ltd(300024) surgery can really achieve the effect of multi hole surgery in many cases, and we think domestic brands also have the strength to compete with imported products. ” Professor Wang linhui said.
“If you want me to give it a score of 80. In the future, I believe that high-end medical devices such as surgery Siasun Robot&Automation Co.Ltd(300024) are no longer European and American patents, and our domestic surgery Siasun Robot&Automation Co.Ltd(300024) will benefit more patients.” Professor Wang linhui said.
(Financial Associated Press)
